SCHEMBL9429388

SCHEMBL9429388

CC(C)(C)c1ccc(-c2ccc(N)s2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.49
RAB9A P51151 5/20 0.49
KDM4E B2RXH2 2/20 0.49
APP P05067 3/20 0.45
TP53 P04637 2/20 0.43
ALDH1A1 P00352 2/20 0.43
MITF O75030 1/20 0.43
KMT2A Q03164 1/20 0.43
CYP2E1 P05181 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2A6 P11509 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2B6 P20813 1/20 0.43
CYP2C19 P33261 1/20 0.43
KIF11 P52732 3/20 0.41
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
PRKDC P78527 1/20 0.39
DGAT1 O75907 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19735284 0.85 APP (0.48) NPC1RAB9AKDM4EAPPTP53
SCHEMBL9428728 0.80 KIF11 (0.52) APPCYP2E1CYP3A4CYP2D6CYP2A6
SCHEMBL1622295 0.78 KIF11 (0.47) NPC1RAB9AKDM4EAPPTP53
SCHEMBL17994290 0.78 HSD17B1 (0.52) NPC1RAB9AKDM4EAPPALDH1A1
SCHEMBL19318455 0.78 TNF (0.42) NPC1RAB9AKDM4EAPPTP53
SCHEMBL9429302 0.77 APP (0.50) KDM4EAPPALDH1A1CYP2E1CYP3A4
SCHEMBL9912044 0.76 APP (0.76) APPTP53ALDH1A1KMT2ACYP2E1
SCHEMBL27961812 0.76 POLB (0.46) NPC1RAB9AKDM4EAPPKMT2A
SCHEMBL15070061 0.76 SNCA (0.52) NPC1RAB9AKDM4EAPPTP53
SCHEMBL27961851 0.76 APP (0.41) NPC1RAB9AKDM4EAPPTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5328907-A Treatment of allograft rejection in mammals and antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1994-07-12 US disclosed
US-5108999-A For treating inflammation, autoimmune disease or allograft rejection in mammals SYNTEX (U.S.A.) INC. (US) 1992-04-28 US disclosed
EP-0440503-A1 4-Isoxazolecarboxamide derivatives SYNTEX (U.S.A.) INC. (US) 1991-08-07 EP disclosed
US-5001124-A 4-isoxazolecarboxamide derivatives SYNTEX (U.S.A.) INC. (US) 1991-03-19 US disclosed